Omalizumab Seems Safe, Effective for Real-World Chronic Idiopathic Urticaria Omalizumab Seems Safe, Effective for Real-World Chronic Idiopathic Urticaria

In real-world patients with chronic idiopathic urticaria (CIU), omalizumab meets or exceeds the safety and efficacy results seen in clinical trials, researchers say.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology News Source Type: news